How Do Ozempic, Mounjaro & Other GPL-1 Agonists Work? | Dr. Zachary Knight & Dr. Andrew Huberman скачать в хорошем качестве

How Do Ozempic, Mounjaro & Other GPL-1 Agonists Work? | Dr. Zachary Knight & Dr. Andrew Huberman

Dr. Zachary Knight and Dr. Andrew Huberman discuss the development of GLP-1 drugs like Ozempic for diabetes and weight loss, examining their historical origins, biological mechanisms, and impact on appetite and metabolism. Dr. Zachary Knight is a professor of physiology at the University of California, San Francisco (UCSF), and Howard Hughes Medical Institute (HHMI) investigator. Dr. Andrew Huberman is a tenured professor of neurobiology and ophthalmology at Stanford University School of Medicine and host of the Huberman Lab podcast. Watch the full episode:    • The Science of Hunger & Medications to Com...   Show notes: https://www.hubermanlab.com/episode/d... Timestamps 00:00 Introduction to Weight Loss Challenges 00:06 The Discovery of GLP-1 & Its Origins 01:35 Understanding the Incretin Effect 02:58 The Role of GLP-1 in Diabetes Treatment 04:39 Challenges & Innovations in GLP-1 Drug Development 05:52 Breakthroughs in GLP-1 Drugs for Weight Loss 10:47 Mechanisms of GLP-1 Drugs in the Brain 13:39 Conclusion & Further Insights #HubermanLab #Science #GLP1 Disclaimer & Disclosures: https://www.hubermanlab.com/disclaimer